# CAR-T cell therapy: Evolution

Source page: https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-evolution/

#### Timeline

The milestones from first idea to today

| Year | Milestone |
|---|---|
| 1989 | Gross, Waks and Eshhar publish the first chimeric antigen receptors ^[2] |
| 2010 | CTL019, later Kymriah, is first tested at Penn in adults with chronic lymphocytic leukaemia ^[4] |
| 2012 | The Children's Hospital of Philadelphia begins studying it in children with leukaemia; Penn and Novartis start a global collaboration ^[4] |
| 2017 | The FDA approves Kymriah on 30 August, the first CAR-T therapy ^[3]; a second follows that year ^[8] |
| 2025 | Seven CAR-T therapies are approved in the United States ^[1] |

as of 2026-11-11

#### Lineage

The technologies it came from and the ones that came from it
 Came before it

- [mAb Monoclonal antibodies](https://www.materialinsights.org/technologies/monoclonal_antibodies/) Monoclonal antibodies made it possible to choose a marker to aim at; the 1989 receptors gave T cells antibody-type specificity ^[2].
 Builds on

- [rDNA Recombinant DNA (genetic engineering)](https://www.materialinsights.org/technologies/recombinant_dna/) Kymriah was the first therapy based on gene transfer approved by the FDA ^[4].

as of 2026-11-11

#### Sources

1. [CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers](https://www.cancer.gov/about-cancer/treatment/research/car-t-cells) National Cancer Institute (NIH), 2025
2. [Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity](https://www.migal.org.il/en/node/5851) Proceedings of the National Academy of Sciences (Gross, Waks, Eshhar), record at MIGAL, 1989
3. [FDA Approves Novartis' CAR-T Drug, First Gene Therapy Approval in US](https://www.pharmtech.com/view/fda-approves-novartis-car-t-drug-first-gene-therapy-approval-us-0) Pharmaceutical Technology, 2017
4. [FDA Approves Personalized Cellular Therapy for Advanced Leukemia (news release)](https://pennmedicine.org/news/news-releases/2017/august/fda-approves-personalized-cellular-therapy-for-advanced-leukemia) Penn Medicine, 2017
5. [Cells as cancer drugs](https://ccr.cancer.gov/news/horizons/article/cells-as-cancer-drugs) National Cancer Institute, Center for Cancer Research

## Other sections

- [Summary](https://www.materialinsights.org/technologies/car_t_cell_therapy/index.md)
- [Overview](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-science/index.md)
- [Materials](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-industries/index.md)
